News and Events

Ear Institute of Chicago, LLC Picture of ear
Our Practice Contact Us Ear Surgery Medical Info Hearing Aids Patient Services

Home Page
Our Practice
Office Locations
New Hinsdale Location
Office Hours
Physicians
Richard Wiet, MD
Additonal Info
Robert Battista, MD
Additional Info
Arvind Kumar, MD
Additional Info
Audiologists
Lois Adamiec
Kathy Highhouse
Kyrstine Mullins
Vasilike Rauch
Hearing/Balance Tests
Hospital Affiliations
Office Policies
Insurance
Mission Statement
Disclaimer
Contact Us
Cochlear Implants
How It Works
Types of Implants
Who is a Candidate
What is Involved
Comparison of Implants
FAQ
Implantable Hearing Devices
Baha
Vibrant Soundbridge
Comparison of Hearing Devices
Ear Surgery
Stapedectomy
Tympanoplasty
Overlay vs. Underlay
Mastoidectomy
Canal wall down vs. wall up
Benign positional vertigo surgery
Techniques
Gamma Knife Radiosurgery
Steps of the Procedure
What to expect: FAQ
Medical Information
Acoustic Neuroma
Benign Positional Vertigo
Cholesteatoma
Dizziness
Facial Paralysis
Bell's Palsy
Herpes Zoster Oticus
Hearing Loss
How We Hear
Effects of Hearing Loss
Quick Hearing Test
Meniere's Disease
Otosclerosis
Skull Base Tumors
Acoustic Neuroma
Facial Neuroma
Glomus Tumors
Glomus Tympanicum
Glomus Jugulare
Meningioma
Sudden Hearing Loss
Hearing Aids
Types of Aids
Choosing an Aid
Hearing Aid Care
Dispensing Policies
FAQ
Patient Services
Office Forms
Post-Operative Instructions
FAQ
HIPAA
Newsletter: Sign Up!
Newsletter
News/Events

Acoustic Neuroma

What is an Acoustic Neuroma?

How is the tumor identified?

What treatments are available for acoustic neuroma?

Observation

Surgical Treatment

Stereotactic Radiation

The Ear Institute of Chicago experience with acoustic neuroma


What is an Acoustic Neuroma?


An acoustic neuroma (also called a schwannoma or neurinoma) is a benign (non-cancerous) tissue growth that arises from the balance nerve. There are two balance (vestibular) nerves, one for each of the right and left ears. The balance nerve is a thin cord that starts at the base of the brain and travels through a small, bony canal (internal auditory canal) of the skull to the inner ear. Two other nerves, the hearing nerve and the facial nerve (7th cranial nerve), travel directly alongside the balance nerve through the internal auditory canal to the inner ear.

Small acoustic neuroma in the internal auditory canal.

Acoustic neuromas commonly develop inside the internal auditory canal. These tumors usually grow slowly over a period of many years. When acoustic neuromas grow in size, the tumor compresses the hearing nerve. Therefore, hearing loss is the first symptom in over 90% of patients with acoustic neuroma. Tinnitus or ear noise is also a common symptom. Loss of balance, dizziness or facial weakness may develop as the tumor continues to grow.

back to the top

Identifying the Tumor


With appropriate tests it is now possible to identify tumors as small as 1-3mm in size. The first step in identifying a possible tumor is a thorough history and physical examination by a physician. Hearing testing is performed to identify any loss of hearing or speech understanding. An auditory brainstem response test (abbreviated ABR, BAER, or BSER) is ordered if there are any asymmetries in hearing testing between the right and left ears. An ABR provides information on the passage of an electrical impulse along the hearing nerve from the ear to the brain. Abnormal ABR results suggest a poorly functioning hearing nerve. A detailed "imaging" is ordered if there is an abnormality of the ABR test.

The most accurate imaging technique for acoustic neuroma identification is a magnetic resonance imaging (MRI). A properly performed MRI can identify acoustic neuromas as small as 2-3mm. MRI uses magnetic pulses and radio frequency waves to produce an image of a portion of the body being studied. Radiation is not used to perform an MRI. A contrast material, gadolinium, is given during the MRI to enhance the visibility of the tumor.

back to the top

Treatment of Acoustic Neuroma


Observation
Since acoustic neuromas are benign, often slow-growing tumors, careful observation over a period of time may be appropriate for some patients. When a small tumor is discovered in an older patient, observation to study the growth rate of the tumor may be indicated if acute symptoms are not present. A MRI scan of the tumor and surrounding region must be performed periodically to determine if there is any significant change in the size of the tumor. If the tumor does not grow, observation is continued. If the tumor increases in size, treatment may be recommended.

Surgical Removal
There are several surgical approaches that may be used to remove an acoustic tumor. The type of approach is individualized depending on the patient's wishes, hearing level, other neurological symptoms, and location and size of the tumor. The Ear Institute of Chicago, LLC is well versed in all surgical approaches for acoustic neuroma management.

Middle Fossa Approach
In the middle fossa approach, the bone is opened above the ear and the bone overlying the tumor is removed. The inner ear is not entered. Therefore, hearing preservation is possible. The middle fossa approach is most suitable for small tumors with good hearing.

Retrosigmoid Approach
In this approach, the bone is opened behind both the mastoid bone and the inner ear. In this way the tumor is removed from behind the inner ear. Retrosigmoid removal also allows the possibility of hearing preservation and may be used for both small and large tumors.

Translabyrinthine Approach
In the translabyrinthine approach, the mastoid bone behind the ear is removed and the inner ear is opened. This exposes the internal auditory canal directly. All hearing is lost with this approach. The translabyrinthine approach is, therefore, used only for those cases where hearing loss is already severe or the tumor is so large that hearing conservation is not a realistic goal.

Hospital stay after any type of microsurgery ranges from 4-7 days. Approximately 4-6 weeks is suggested for recovery.

back to the top

Stereotactic Radiation Therapy
Stereotactic radiation therapy, which is commonly known as "radiosurgery," is a single session radiation treatment. Using computer imaging, a single, high dose of radiation is delivered to the acoustic tumor while minimizing injury to surrounding nerves and brain tissue. Treatment is often performed on an outpatient basis.
Stereotactic radiation prevents further tumor growth and sometimes shrinks a portion of the tumor. This type of treatment does not remove the tumor. Follow-up imaging studies are important because some tumors will continue to grow after stereotactic radiation. For more information regarding Stereotactic Radiation Therapy, please click here.

Each form of acoustic neuroma treatment, either surgery or radiation, has advantages and disadvantages. Many factors are used to determine the most appropriate type of treatment.

back to the top

Ear Institute of Chicago and Acoustic Neuroma


The Ear Institute of Chicago, LLC has a combined experience with over 1000 patients with acoustic neuroma during a 20-year period. This makes the Ear Institute of Chicago, LLC one of the largest acoustic neuroma centers in the United States.

The group is well versed in all aspects of management of acoustic neuromas. The physicians are capable of performing all surgical approaches for acoustic neuroma removal, including the translabyrinthine, retrosigmoid, and middle fossa approaches. A wait and see approach is also used in selected cases depending on symptoms and the size/location of the tumor.
The type of management is individualized depending on the patient's wishes, hearing level, other neurological symptoms, and location and size of the tumor. The final choice is one that will provide the most ethical outcome.
The Ear Institute of Chicago, LLC maintains an outcome database based on the treatment of over 1000 patients with acoustic neuroma during the past 15 years. The database is used to improve treatment techniques by evaluating the group's microsurgical outcomes.
Acoustic neuroma research is a large part of the practice of the Ear Institute of Chicago. The group is currently working with Northwestern Memorial Hospital to evaluate several disease specific issues regarding acoustic neuromas. These issues include the epidemiology, the genetics, and the molecular biology of acoustic neuromas. The ultimate goal of this study is to determine the factors that lead to the best management of a patient with an acoustic neuroma.

The following tables summarize the acoustic neuroma operative experience and results of the Ear Institute of Chicago from 1982 - 1998 (updated August 1998):

Operative Approach
Number of Cases (percentage)
(N = 444)
Translabyrinthine
293 (66%)
Retrosigmoid
75 (17%)
Middle fossa
26 (6%)
Modified translabyrinthine
10 (2%)
Other
40 (9%)
Table 1. Ear Institute of Chicago operative approach for acoustic neuroma from 1982 -1998.

Operative Approach
Percentage (%) Hearing Preservation
Retrosigmoid
41% (27 of 66 cases)
Middle Fossa
38% (10 of 26 cases)
Table 2. Ear Institute of Chicago hearing preservation rates. Hearing preservation is defined as greater than 50dB pure tone average and greater than 50% word recognition score.
House-Brackmann
Facial Nerve Grade
Percentage (%)
I
60%
II
15%
III
11%
IV
7%
V
2%
VI
5%

Table 3. Facial nerve function after translabyrinthine approach. Facial nerve results are documented 12 months or longer after surgery. Results are for tumors of all sizes. (House-Brackmann facial nerve grade: grade I = normal movement, grade VI = no facial movement)

back to the top

 


 
HOME
DISCLAIMER
| CONTACT US | HIPAA
© 2008 Ear Institute of Chicago, LLC